WHNT: George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III ... Multi-mechanism, triple combination of existing best-in-class medicines in novel low dose single pill, GMRx2 has potential to be the only triple combination product for management of hypertension, ... George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III ...

Context Explanation

MSN: Resistant hypertension: The dangerous type of high blood pressure that medicines can't fix Resistant hypertension: The dangerous type of high blood pressure that medicines can't fix KOLR10 & Ozarks Local News: George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including ... George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including ... AHA/ASA Journals: Association Between Social Determinants of Health and Adherence to Antihypertensive Medications in US Patients With Uncontrolled, Treated Hypertension